A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris

NCT02411955 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

1077

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Tazarotene Cream 0.1%
DRUG: Tazorac®
DRUG: Placebo

Sponsor

Sun Pharmaceutical Industries, Inc.